PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Incyte Corporation
M.D. Anderson Cancer Center
University of Washington
Takeda
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
Novartis
Mayo Clinic
Italfarmaco
Incyte Corporation
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center